Ambeed.cn

首页 / 重组蛋白 / / / Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293)

Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) {[allProObj[0].p_purity_real_show]}

货号:A2925448 同义名: 重组人VSIG4蛋白(C-Fc, HEK293) / Recombinant Human VSIG4 (C-Fc, HEK293); V-set and immunoglobulin domain-containing protein 4

Recombinant Human VSIG4 (C-Fc, HEK293) 是人源VSIG4蛋白,在HEK293细胞中表达,带有C端Fc标签。该蛋白是一种跨膜免疫调节蛋白,结构与B7家族相关,可结合补体片段C3b和iC3b,是T细胞增殖和IL-2产生的强效负调控因子,同时抑制补体旁路途径转化酶,主要高表达于肺、胎盘及静息巨噬细胞中。

Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 化学结构 CAS号:N/A
Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 化学结构
CAS号:N/A
Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 3D分子结构
CAS号:N/A
Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 化学结构 CAS号:N/A
Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 3D分子结构 CAS号:N/A
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 纯度/质量文件 产品仅供科研

货号:A2925448 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 生物活性

描述 V-set and immunoglobulin domain-containing protein 4(VSIG4) is a transmembrane protein contains a signal peptide, a V-type Ig-like domain, a C2-type Ig-like domain, several potential O-glycosylation sites, and an intracellular domain with 2 potential phosphorylation sites and is structurally related to the B7 family of immune regulatory proteins. This protein is also a receptor for the complement component 3 fragments C3b and iC3b.The main function is strong negative regulator of T-cell proliferation and IL2 production and it is also potent inhibitor of the alternative complement pathway convertases. It abundantly expressed in several fetal tissues such as adult tissues, highest expression in lung and placenta and it also expressed in resting macrophages.
蛋白种属 Human
表达系统 Human Cells
标签 C-Fc
蛋白表达区间 Arg20-Val284
蛋白编号 Q9Y279
内毒素 < 1 EU/µg as determined by LAL test.
剂型 干粉
剂型描述 Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
复溶 Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
如要长期保存,建议使用含载体蛋白(如 0.1%BSA、10%FBS、5%HSA)的溶液进一步稀释,如果是做无血清培养或者动物体内实验时,细胞因子中不能含有BSA、FBS 和 HAS,可以使用海藻糖作为载体,然后分装冻存于-20℃至-80℃。
注:分装保存时建议使用低吸附的管子,并避免反复冻融;稀释分装浓度不低于 10μg/mL,分装体积不低于10μL。
分装后的蛋白在≤-20°C 下可稳定保存 3 个月。

Human VSIG4 (C-Fc, HEK293)/人VSIG4蛋白(C-Fc, HEK293) 技术信息

CAS号N/A
分子量 56.3 KDa
SMILES Code NONE
别名 重组人VSIG4蛋白(C-Fc, HEK293) ;Recombinant Human VSIG4 (C-Fc, HEK293); V-set and immunoglobulin domain-containing protein 4; VSIG4; Protein Z39Ig; Z39IG; CRIg
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。